Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 24.03.2026
WATO Members Club
PARIS, March 24, 2026 /PRNewswire/ -- After ten years organizing spectacular bespoke events for billionaires and major corporations, event artist Foulques Jubert, and founder of the WATO agency, has decided to issue a call to the world's greatest lovers of costumed celebrations.
Aficionados of international masquerade balls of Versailles, Veni [ … ]
Tue, 24.03.2026
OverIT
MILAN, March 24, 2026 /PRNewswire/ -- Empresas Públicas de Medellín (Grupo EPM), one of the largest and most prestigious multi-utility enterprises in Latin America, has selected OverIT as its strategic Field Service Management (FSM) software solution.
Headquartered in Medellín with operations spanning Colombia, Central America, Chile, and Mexico, [ … ]
Tue, 24.03.2026
Rentschler Biopharma SE
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion
Milford, Massachusetts site event recognizes achievements, strong performance, and growing client base since completion of major U.S. expansion
U.S. site established as cornerstone of the company’s strategy, delivering reliable, tailored CDMO [ … ]
Tue, 24.03.2026
Green GSM
EQS Newswire / 24/03/2026 / 13:15 CET/CEST
ANTIPOLO CITY, PHILIPPINES - Media OutReach Newswire - 24 March 2026 - Green Xentro has launched the initial phase of a 2,500-unit fleet of fully electric (BEV) taxis in Rizal province, under a strategic partnership with the global mobility platform Green GSM. This marks one of the largest BEV ta [ … ]
Tue, 24.03.2026
Discovery Life Sciences
New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug development
HUNTSVILLE, Ala. and HAMBURG, Germany, March 24, 2026 /PRNewswire/ -- Inconsistent biomarker interpretation across pathologists remains one of the more stubborn challenges in clinical trial development, contributing to var [ … ]
Tue, 24.03.2026
Aroundtown SA
Company Name:
Aroundtown SA
ISIN:
LU1673108939
Reason for the research:
Jahresbericht 2025
Recommendation:
Kaufen
from:
24.03.2026
Target price:
€4,10
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Aroundtown SA (ISIN: LU1673108939) v [ … ]
Tue, 24.03.2026
Athena Intelligence
Aditya Jain appointed to lead expansion, backed by senior Indian defence and law enforcement figures
GENEVA, March 24, 2026 /PRNewswire/ -- Athena Intelligence, the Geneva-based corporate investigations and risk advisory firm, is expanding into India as demand accelerates for cross-border intelligence and financial crime expertise.
The firm has ap [ … ]
Tue, 24.03.2026
TÜRKÇİMENTO
EQS-Media / 24.03.2026 / 12:23 CET/CEST
Turkish cement producers warn that EU CBAM default emission values significantly overstate actual emissions, raising carbon costs from €20 to €80 per ton. They call for recognition of EU-aligned national MRV data to prevent disproportionate financial burdens and safeguard fair competition.
Ankara — The [ … ]
Tue, 24.03.2026
Hong Kong Science and Technology Parks Corporation
EQS Newswire / 24/03/2026 / 12:15 CET/CEST
Driving "Attract In" and "Go Global", Accelerating Hong Kong's Greentech Ecosystem DevelopmentHONG KONG SAR - Media OutReach Newswire - 24 March 2026 - Hong Kong Science and Technology Parks Corporation (HKSTP) today hosted the "Green is Action: GreenTech Hub 1st Anniversary Showcase" at InnoCentre in [ … ]
Tue, 24.03.2026
VinFast
EQS Newswire / 24/03/2026 / 11:30 CET/CEST
JAKARTA, INDONESIA - Media OutReach Newswire - 24 March 2026 - In Indonesia, where motorbikes have long dominated daily mobility, transitioning to a car has traditionally been seen as a major leap, one associated with higher costs, lifestyle adjustments, and urban constraints. However, the arrival of [ … ]
